etiolog
communityacquir
pneumonia
cap
determin
less
half
patient
base
cultur
sputum
blood
plu
test
urin
antigen
streptococcu
pneumonia
legionella
pneumophila
studi
ad
nasal
polymeras
chain
reaction
pcr
probe
pneumonia
staphylococcu
aureu
respiratori
virus
serum
procalcitonin
pct
level
measur
pathogen
identifi
patient
detect
virus
patient
random
either
laboratorygener
pcr
bundl
filmarray
pcr
platform
filmarray
pcr
platform
detect
virus
laboratorygener
bundl
less
hour
fewer
day
antibiot
therapi
p
cap
patient
viral
infect
low
serum
pct
level
clinic
guidelin
call
earli
initi
empir
antibiot
therapi
patient
communityacquir
pneumonia
cap
mandel
et
al
admit
via
emerg
depart
ed
recommend
antibacteri
therapi
start
ed
mandel
et
al
deescal
discontinu
recommend
result
microbiolog
test
avail
howev
diagnost
yield
cultur
sputum
blood
plu
probe
urin
antigen
streptococcu
pneumonia
legionella
pneumophila
musher
et
al
result
tradit
diagnost
eg
sputum
cultur
avail
day
result
often
broad
multidrug
empir
antibiot
regimen
often
prolong
physician
may
will
discontinu
empir
antibiot
despit
identif
potenti
viral
pathogen
provid
oft
time
express
fear
concomit
invas
bacteri
pathogen
could
present
found
later
sputum
cultur
address
issu
protocol
includ
least
baselin
serum
procalcitonin
pct
level
gener
accept
serum
pct
level
increas
substant
pure
viral
respiratori
tract
infect
becker
et
al
gilbert
addit
pct
level
may
help
interpret
cultur
data
pneumonia
moraxella
catarrhali
haemophilu
influenza
may
airway
chronic
obstruct
pulmonari
diseas
patient
pct
level
increas
unless
latter
caus
invas
infect
falsey
et
al
studi
design
address
question
first
expans
tradit
diagnost
test
bundl
substant
increas
detect
potenti
etiolog
organ
second
molecular
diagnost
provid
clinician
action
data
hour
rather
day
lastli
provid
respond
rapid
diagnost
data
adjust
empir
antibiot
treatment
regimen
studi
conduct
nonblind
cluster
random
trial
commun
teach
hospit
portland
oregon
provid
portland
medic
center
ppmc
prior
initi
studi
research
project
approv
institut
review
board
irb
privaci
board
ppmc
deidentifi
chart
data
collect
irb
indic
need
inform
consent
studi
inform
form
avail
enrol
patient
prior
studi
initi
investig
review
studi
protocol
ed
nurs
physician
clerk
health
unit
coordin
similar
meet
conduct
hospitalist
resid
diagnosi
cap
made
ed
physician
ed
physician
determin
need
hospit
patient
enrol
studi
ed
physician
use
hospit
electron
medic
record
emr
order
protocolmand
diagnost
bundl
instruct
health
unit
coordin
notifi
investig
new
patient
ed
physician
initi
empir
antibiot
therapi
protocol
dictat
suggest
antibiot
manag
either
ed
inpati
physician
diagnost
test
bundl
see
initi
ed
nurs
staff
vast
major
patient
provid
learn
test
result
via
post
emr
except
per
hospit
polici
provid
immedi
notifi
directli
usual
nurs
unit
nurs
clerk
posit
blood
cultur
identif
influenza
inpati
physician
provid
offici
notifi
patient
studi
although
prestudi
educ
session
awar
hospitalwid
cap
diagnost
studi
investig
process
test
bundl
order
ed
indic
studi
particip
common
core
diagnost
test
bundl
appli
patient
studi
ie
blood
cultur
sputum
cultur
sensit
serum
pct
level
urin
antigen
test
l
pneumophila
serogroup
pneumonia
patient
nasal
swab
polymeras
chain
reaction
pcr
detect
lyt
gene
pneumonia
meca
nuc
gene
staphylococcu
aureu
pcr
pneumonia
inhous
laboratorygener
test
avail
number
year
supplement
pneumonia
urin
antigen
pcr
aureu
purchas
bectondickinson
bd
max
staph
sr
pct
level
determin
use
immunoassay
develop
brahm
market
perform
vida
system
interpret
algorithm
provid
pcr
result
protocol
call
baselin
pct
serum
level
provid
order
addit
level
discret
pct
result
includ
interpret
algorithm
model
format
use
multipl
european
studi
schuetz
et
al
schuetz
et
al
valu
ngml
interpret
bacteri
etiolog
unlik
valu
ngml
bacteri
etiolog
like
valu
ngml
bacteri
etiolog
like
algorithm
suggest
repeat
pct
level
hour
patient
level
ngml
clinic
pictur
compat
evolv
bacteri
infect
addit
common
bundl
patient
cluster
random
block
undergo
addit
diagnost
test
either
ppmc
laboratorygener
respiratori
pathogen
pcr
panel
standard
commerci
faster
broader
multiplex
pcr
panel
filmarray
ppmc
laboratorygener
pcr
panel
probe
influenza
b
adenoviru
human
metapneumoviru
respiratori
syncyti
viru
rhinoviru
specimen
run
day
least
day
per
week
result
gener
avail
within
hour
altern
week
nasopharyng
np
swab
process
filmarray
multiplex
pcr
panel
biofir
salt
lake
citi
ut
usa
filmarray
panel
detect
nucleic
acid
type
influenza
type
parainfluenza
rhinovirusenteroviru
adenoviru
human
metapneumoviru
type
coronaviru
respiratori
syncyti
viru
mycoplasma
pneumonia
chlamydophila
pneumonia
bordetella
pertussi
filmarray
assay
take
minut
total
time
specimen
collect
report
result
emr
roughli
hour
panel
intern
medicin
resid
see
acknowledg
extract
data
patient
emr
patient
assign
studi
number
databas
file
filemak
pro
establish
data
extract
began
enrol
continu
period
hospit
complet
postdischarg
data
entri
check
verifi
author
addit
infecti
diseas
pharmacist
enter
data
refer
use
antibiot
andor
antiinfluenza
therapi
use
standard
list
purchas
expens
individu
antibiot
investig
dng
determin
day
expens
antimicrobi
therapi
given
day
empir
therapi
differ
antibiot
regardless
number
dose
defin
day
therapi
dot
length
number
day
therapi
lot
regardless
number
drug
administ
day
also
calcul
day
antibiot
therapi
length
antibiot
therapi
normal
hospit
patient
day
inclus
requir
ed
diagnosi
cap
suffici
sever
requir
hospit
postdiagnosi
ed
physician
enrol
patient
initi
appropri
order
set
patient
requir
year
age
older
patient
exclud
possibl
obtain
np
swab
decid
withhold
antibiot
initi
comfort
care
manag
postenrol
patient
exclud
henc
nonevalu
site
infect
present
eg
cap
plu
noncap
infect
final
databas
enrol
patient
review
investig
jl
dng
purpos
final
categor
per
definit
event
disagr
case
adjud
third
investig
gg
criteria
assign
final
clinic
diagnosi
follow
postadmiss
clinic
laboratori
imag
studi
document
altern
noninfecti
diagnosi
congest
heart
failur
exampl
proven
presenc
bacteri
pathogen
sputum
blood
pleural
fluid
also
accept
presenc
pneumonia
np
swab
pcr
andor
posit
pneumonia
urin
antigen
patient
clinic
syndrom
pneumonia
absenc
detect
pathogen
presumpt
presenc
multifoc
pulmonari
infiltr
detect
pneumonia
aureu
pcr
nasal
swab
patient
clinic
syndrom
pneumonia
possibl
obtain
sputum
bronchoalveolar
lavag
specimen
presenc
clinic
pneumonia
serum
pct
level
ngml
accept
presumpt
evid
bacteri
pneumonia
absenc
detect
bacteri
pathogen
common
exampl
patient
document
aspir
ngml
cutoff
use
base
larg
number
european
trial
pct
level
patient
varieti
lower
respiratori
tract
infect
schuetz
et
al
schuetz
et
al
identif
presenc
adenoviru
coronaviru
human
metapneumoviru
parainfluenza
respiratori
syncyti
viru
rhinoviru
pcr
probe
compat
clinic
syndrom
patient
consid
coinfect
diagnost
data
demonstr
presenc
viral
bacteri
pathogen
respiratori
viru
detect
serum
pct
ngml
andor
bacteri
pathogen
found
sputum
cultur
patient
assum
dual
infect
identifi
viru
bacteria
detect
bacteri
viral
pathogen
identifi
potenti
etiolog
agent
seroconvers
studi
perform
document
invas
diseas
patient
file
review
investig
gg
jl
dg
patient
consid
evalu
protocolrequir
diagnost
studi
perform
sputum
cultur
sensit
except
absenc
sputum
cultur
accept
due
dilig
sputum
could
obtain
patient
consid
nonevalu
diagnost
panel
incomplet
patient
die
within
hour
diagnosi
cap
incorrect
patient
dual
infect
eg
cap
urinari
tract
infect
uti
patient
file
review
investig
determin
patient
pneumonia
diagnosi
hindsight
correct
patient
clinic
pneumonia
syndrom
investig
classifi
etiolog
pneumonia
way
viral
bacteri
combin
viral
bacteri
pathogen
found
clinic
pneumonia
unclear
etiolog
respiratori
viru
detect
associ
bacteri
infect
deem
present
bacteri
pathogen
identifi
cultur
pcr
urin
antigen
serum
pct
concentr
ngml
comparison
diagnost
method
test
wilcoxon
test
perform
continu
variabl
chisquar
test
fisher
exact
test
perform
categor
variabl
kruskalw
test
analysi
varianc
test
use
comparison
among
distinct
etiolog
group
viral
bacteri
combin
viral
bacteri
januari
march
ed
admit
patient
diagnosi
cap
standard
ppmc
diagnost
week
patient
enrol
filmarray
week
patient
enrol
fig
patient
standard
group
patient
nonevalu
due
failur
obtain
element
protocolrequir
diagnost
bundl
patient
presenc
noninfecti
diseas
caus
pulmonari
infiltr
eg
congest
heart
failur
patient
document
presenc
second
site
activ
infect
eg
uti
patient
remain
standard
patient
pathogen
identifi
patient
filmarray
group
patient
evalu
patient
failur
obtain
element
diagnost
bundl
patient
final
clinic
diagnosi
exclud
pneumonia
patient
second
site
activ
infect
remain
patient
pathogen
identifi
patient
high
rate
incomplet
diagnost
larg
result
problem
order
set
emr
hospit
instal
new
emr
despit
order
proper
bundl
emr
either
fail
input
complet
order
set
andor
fail
notifi
nurs
staff
order
problem
gradual
rectifi
first
week
studi
note
nonevalu
patient
otherwis
similar
evalu
respect
demograph
comorbid
featur
list
tabl
demograph
clinic
featur
differ
standard
filmarray
patient
tabl
elev
pneumonia
sever
index
valu
support
need
hospit
becker
et
al
select
comorbid
evenli
distribut
filmarray
patient
prescrib
outpati
oral
antibiot
immedi
prior
hospit
p
combin
patient
enrol
standard
filmarray
group
potenti
pathogen
identifi
patient
evalu
patient
posit
test
patient
group
identifi
tabl
patient
respiratori
viru
detect
patient
potenti
bacteri
pathogen
found
patient
potenti
viral
bacteri
pathogen
detect
common
diagnost
bundl
hospit
patient
cap
combin
cultur
sputum
blood
plu
detect
antigen
pneumonia
l
pneumophila
urin
howev
abl
obtain
valid
sputum
specimen
cultur
evalu
patient
overal
posit
sputum
cultur
occur
patient
posit
blood
cultur
patient
posit
urin
antigen
test
patient
short
tradit
test
combin
would
identifi
potenti
etiolog
pathogen
patient
tabl
diagnost
yield
increas
np
swab
pneumonia
pcr
anterior
nasal
swab
aureu
pcr
although
pneumonia
detect
blood
cultur
patient
urin
antigen
patient
np
pcr
patient
tabl
aureu
detect
sputum
patient
anterior
nasal
swab
patient
sum
ad
pneumonia
aureu
pcr
posit
result
increas
posit
diagnost
yield
patient
addit
probe
respiratori
virus
detect
viru
evalu
patient
patient
identifi
pathogen
hospit
standard
pcr
panel
detect
viru
patient
versu
filmarray
detect
viru
patient
coronaviru
part
hospit
pcr
panel
detect
patient
filmarray
also
detect
c
pneumonia
patient
note
influenza
detect
patient
random
filmarray
detect
standard
panel
earli
januari
hypothes
discrep
larg
due
time
enrol
studi
initi
second
week
januari
ppmc
standard
panel
statewid
influenza
surveil
indic
influenza
activ
occur
novemb
decemb
larg
disappear
midjanuari
turnaround
time
process
run
report
target
filmarray
multiplex
pcr
panel
hour
compar
hour
ppmc
viru
standard
pcr
viral
panel
p
b
time
result
urin
antigen
pneumonia
l
pneumophila
rang
hour
pcr
nasal
secret
aureu
pneumonia
result
report
hour
henc
filmarray
pcr
provid
quickest
turnaround
time
admiss
serum
pct
concentr
mean
ngml
patient
viral
pathogen
present
patient
infect
bacteri
pathogen
mean
valu
ngml
bacteri
viral
pathogen
detect
mean
valu
ngml
fig
differ
viral
group
either
group
highli
statist
signific
p
b
instanc
serum
pct
help
distinguish
colon
invas
patient
np
swab
posit
human
metapneumoviru
nasal
pcr
also
posit
mrsa
pct
level
normal
treatment
mrsa
given
per
clinic
guidelin
manag
patient
cap
suffici
sever
requir
hospit
enrol
evalu
patient
receiv
first
dose
empir
antibiot
therapi
within
hour
arriv
leav
ed
mandel
et
al
order
determin
influenc
aggress
diagnost
test
patient
care
antibiot
dot
normal
patient
day
lot
per
patient
day
dollar
cost
therapi
per
patient
day
determin
tabl
dot
significantli
lower
virusonli
group
p
trend
toward
shorter
lot
virusonli
group
compar
etiolog
categori
regardless
microbi
etiolog
cap
diagnost
bundl
signific
differ
cost
antibiot
ask
faster
result
report
filmarray
panel
would
influenc
antibiot
use
patient
pure
viral
pneumonia
patient
day
n
standard
diagnost
group
n
filmarray
patient
p
patient
np
pcr
detect
pathogen
viru
absenc
pathogen
bacteria
clinic
sign
symptom
white
blood
cell
wbc
differenti
chest
xray
serum
pct
level
consist
viral
pneumonia
nonetheless
patient
empir
antibiot
discontinu
within
hour
physician
receipt
pcr
pct
result
diagnost
bundl
employ
etiolog
pathogen
detect
evalu
patient
use
filmarray
multiplex
pcr
panel
averag
time
detect
viral
pathogen
reduc
less
hour
serum
pct
level
success
separ
pure
viral
infect
bacteri
mix
viralbacteri
pneumonia
although
day
antibiot
therapi
less
pure
viral
infect
full
potenti
antibiot
deescal
achiev
diagnost
bundl
detect
high
percentag
potenti
etiolog
pathogen
total
evalu
patient
candid
etiolog
organ
found
patient
demonstr
pathogen
multiplex
viral
pcr
panel
posit
high
posit
yield
also
result
identif
pneumococcu
pcr
aureu
pcr
diagnost
bundl
limit
cultur
sputum
blood
plu
urin
antigen
diagnost
yield
would
fall
patient
posit
diagnost
test
total
evalu
patient
unabl
obtain
sputum
cultur
patient
total
patient
posit
np
swab
pcr
pneumonia
patient
concomit
posit
pneumonia
urin
antigen
patient
concomit
posit
sputum
cultur
patient
concomit
posit
blood
cultur
b
pneumonia
mssa
c
pneumonia
tuberculosi
report
diagnost
yield
literatur
vari
extent
type
test
perform
studi
pathogen
detect
patient
test
limit
bacteri
cultur
airway
blood
plu
urin
antigen
test
l
pneumophila
restrepo
et
al
studi
patient
israel
put
pathogen
detect
patient
high
yield
achiev
np
swab
subject
pcr
probe
pneumonia
c
pneumonia
l
pneumonia
genera
respiratori
virus
addit
urin
probe
pneumonia
antigen
sequenti
sera
collect
measur
possibl
antibodi
increas
atyp
pathogen
genera
virus
shibi
et
al
also
similarli
exhaust
diagnost
studi
swedish
patient
identifi
etiolog
pathogen
subset
patient
subject
seroconvers
studi
diagnost
yield
impress
johansson
et
al
etiolog
diagnosi
seroconvers
help
epidemiolog
studi
assist
clinic
manag
musher
et
al
attempt
determin
etiolog
cap
adult
patient
admit
year
diagnost
test
includ
blood
airway
cultur
urin
antigen
filmarray
pcr
panel
adequ
sputum
sampl
obtain
case
bacteri
pathogen
found
viral
pathogen
patient
pct
level
elev
patient
bacteri
infect
low
deem
uninfect
viral
infect
emerg
pictur
previous
underappreci
role
viral
pathogen
adult
addit
possibl
find
candid
pathogen
roughli
hospit
patient
cap
purpos
antibiot
stewardship
desir
identifi
pathogen
quickli
possibl
result
confirm
possibl
rapidli
identifi
potenti
etiolog
organ
result
filmarray
avail
within
mean
hour
urin
antigen
hour
laboratorygener
standard
pcr
respiratori
viru
panel
pcr
aureu
pneumonia
within
hour
treat
physician
remain
skeptic
provid
express
worri
might
concomit
bacteri
infect
ad
least
serum
pct
level
larg
number
european
studi
group
unit
state
confirm
pure
viral
infect
result
elev
pct
level
becker
et
al
falsey
et
al
gilbert
schuetz
et
al
schuetz
et
al
serum
level
pct
increas
invas
bacteri
infect
combin
bacterialvir
infect
short
turnaround
time
pct
level
assist
earli
treatment
decis
hypothesi
rapid
identif
microbi
etiolog
would
translat
deescal
specif
therapi
bacteri
pathogen
influenza
antivir
empir
therapi
german
case
viral
pathogen
antibiot
therapi
studi
data
indic
detect
viral
pathogen
concert
low
pct
serum
concentr
result
fewer
day
antibiot
therapi
favor
trend
offset
incomplet
respons
provid
antibiot
discontinu
patient
appar
viral
infect
result
confirm
extend
work
other
oosterheert
et
al
random
adult
patient
lower
respiratori
tract
infect
standard
diagnost
sputum
blood
cultur
plu
urin
antigen
test
l
pneumophila
laboratorygener
multiplex
realtim
pcr
panel
virus
atyp
pathogen
henc
diagnost
bundl
similar
standard
arm
despit
pcr
detect
respiratori
viru
antibiot
therapi
discontinu
patient
author
specul
provid
justifi
continu
antibiot
pend
final
result
sputum
cultur
recent
trial
branch
et
al
employ
protocol
almost
ident
branch
et
al
gilbert
adult
lower
respiratori
tract
infect
random
either
standardofcar
diagnost
intervent
filmarray
platform
pct
level
plu
blood
sputum
cultur
urin
antigen
subgroup
intervent
arm
trend
toward
fewer
day
antibiot
therapi
identifi
viral
pathogen
low
pct
level
fewer
patient
subset
discharg
antibiot
result
latter
trial
data
clearli
demonstr
valu
rapid
diagnost
pct
level
realiz
realtim
commun
member
antibiot
stewardship
team
treat
physician
gilbert
time
repetit
anticip
treat
physician
becom
knowledg
confid
interpret
pcr
pct
result
small
size
studi
group
major
limit
intent
repeat
studi
goal
substant
larger
enrol
studi
differ
other
use
nasal
swab
pcr
pneumonia
aureu
previou
studi
design
determin
etiolog
cap
routin
use
np
swab
pcr
test
detect
pneumonia
rigor
pneumonia
studi
hivinfect
adult
np
swab
perform
well
pcr
probe
sputum
albrich
et
al
henc
difficulti
obtain
valid
sputum
specimen
np
sampl
advantag
eas
specimen
collect
valu
anterior
nasal
swab
pcr
detect
aureu
report
help
patient
ventilatorassoci
pneumonia
leon
et
al
unawar
previou
studi
evalu
perform
aureu
nasal
swab
pcr
standard
part
cap
diagnost
bundl
lastli
perform
acut
convalesc
antibodi
titer
henc
pathogen
detect
may
colon
airway
patient
enrol
consid
evalu
clinic
laboratori
radiograph
pictur
compat
activ
pneumonia
data
present
support
routin
inclus
aureu
pneumonia
nasal
swab
pcr
routin
diagnost
packag
cap
diagnost
bundl
perform
well
identif
candid
etiolog
pathogen
import
respiratori
virus
evid
detect
respiratori
virus
alon
combin
bacteria
evalu
patient
filmarray
pcr
platform
result
serum
pct
level
avail
less
hour
unfortun
full
clinic
benefit
rapidli
detect
airway
viru
low
serum
pct
realiz
result
studi
similar
investig
demonstr
clear
need
expand
antibiot
stewardship
includ
direct
time
discuss
result
diagnost
test
patient
caregiv
